← feed

Is NCT03926416 results overdue?

Yes — results are overdue. Primary completion was 2018-05-29; the FDAAA-801 reporting deadline (2019-05-29) passed 2626 days ago and no results are posted on ClinicalTrials.gov.

Safety Study of Live Attenuated Influenza Vaccine, CodaVax

NCT IDNCT03926416 ↗
SponsorCodagenix, Inc (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-05-29 (ACTUAL)
Reporting deadline2019-05-29 (completion + 365d)
Days overdue2626
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 6254520414990f03… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03926416. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →